Outcome of patients with relapsed or refractory acute myeloid leukemia treated with Mito-FLAG salvage chemotherapy

PURPOSE: Curative intended treatment is challenging in patients with relapsed or refractory acute myeloid leukemia (r/r AML) and associated with a dismal prognosis for long-term survival. Despite novel treatment options, the majority of patients are treated with chemotherapy-based regimens. Although...

Descripción completa

Detalles Bibliográficos
Autores principales: Mühleck, Regina, Scholl, Sebastian, Hilgendorf, Inken, Schrenk, Karin, Hammersen, Jakob, Frietsch, Jochen J., Fleischmann, Maximilian, Sayer, Herbert G., Glaser, Anita, Hochhaus, Andreas, Schnetzke, Ulf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Article – Clinical Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9349069/
https://www.ncbi.nlm.nih.gov/pubmed/34609595
http://dx.doi.org/10.1007/s00432-021-03821-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9349069/
https://www.ncbi.nlm.nih.gov/pubmed/34609595
http://dx.doi.org/10.1007/s00432-021-03821-1

Ejemplares similares